Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000008

Chief Scientific Officer sold 19,360 shares at $31.97 ($618,949)

  • Chief Scientific Officer acquired 19,360 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-04 Exercise or conversion : show line 1 in the form +19,360 $19.47 $376,939 285,282 D
2021-05-04 Sale : show line 2 in the form −19,360 $31.97 $618,949 265,922 D
Open-market sales · 19,360 sh · avg $31.97 · $618,949

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-04 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) −19,360 68,640 D
Loading xslF345X03/edgardoc.xml…